Furthermore, our study has yet to identify the molecular and cellular pathways by which statins regulate PCSK9 for systemic insulin resistance in vivo, though we have shown the important and intriguing observation that GGPP is required for restoring atorvastatin-induced suppression of insulin-AKT signaling in adipose tissue. This evidence concerns the gene INS and Insulin resistance.